Plain-English translation of NCT04371042 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research registry designed to collect medical information, blood samples, and tissue samples from up to 5,000 people with fatty liver disease or related metabolic conditions. By gathering detailed information about patients at different stages of liver disease—from simple fat accumulation to more serious conditions like cirrhosis or liver cancer—researchers hope to better understand how these diseases develop, who is at highest risk, and how to prevent complications.
Fatty liver disease is becoming increasingly common worldwide, especially in people with obesity and diabetes, yet doctors still don't fully understand how it develops or how to predict which patients will get sicker. This registry aims to fill that gap by studying the underlying causes and creating a resource that researchers can use to develop better treatments and prevention strategies.
You likely qualify if…
You likely don't qualify if…
As a participant, you would visit the research center to provide blood and possibly tissue samples, answer medical questionnaires, and allow researchers to access your medical records. The registry is ongoing, so you may be contacted periodically for follow-up information as researchers track how your condition changes over time. There is no medication to take—this is purely an observational study focused on gathering information.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy